[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100598153":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":25,"locations":35,"responsibleParty":61,"collaborators":63,"id":67,"slug":68,"hasResults":69,"nctId":70,"briefTitle":71,"officialTitle":72,"acronym":10,"eligibilityCriteria":73,"healthyVolunteers":74,"sex":75,"minAge":76,"maxAge":10,"enrollmentInfo":77,"targetDuration":10,"studyType":80,"phases":10,"briefSummary":81,"conditions":82,"keywords":84,"overallStatus":38,"whyStopped":10,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"University of Pennsylvania","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Breast imaging in Females",null,"Females who are equal to or greater than 18 years of age are scheduled to have additional imaging due to findings of calcifications or lesions with calcifications on a screening mammogram.",[13],"Diagnostic Test: Breast Imaging",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DIAGNOSTIC_TEST","Breast Imaging","Intervention using an FDA-approved mammogram machine.",[9],[21],{"name":22,"affiliation":23,"role":24},"Brian S Englander, MD","Pennsylvania Hospital","PRINCIPAL_INVESTIGATOR",[26,31],{"name":27,"role":28,"phone":29,"phoneExt":10,"email":30},"Namaijah Faison Clinical Research Coordinator","CONTACT","215-432-5000","Namaijah.Faison@pennmedicine.upenn.edu",{"name":32,"role":28,"phone":33,"phoneExt":10,"email":34},"Jessica Nunez Project Manager","215-829-3712","Jessica.Nunez@pennmedicine.upenn.edu",[36],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Pennsylvania Hospital, Center for Breast Imaging","RECRUITING","Philadelphia","Pennsylvania","19107","United States","US",{"type":45,"coordinates":46},"Point",[47,48],-75.16362,39.95238,{"lat":48,"lon":47},[51,53,56,58],{"name":52,"role":28,"phone":33,"phoneExt":10,"email":34},"Jessica Nunez",{"name":54,"role":28,"phone":55,"phoneExt":10,"email":30},"Namaijah Faison, MPH","267-432-5000",{"name":57,"role":24,"phone":10,"phoneExt":10,"email":10},"Brian S. Englander, MD",{"name":59,"role":60,"phone":10,"phoneExt":10,"email":10},"Elizabeth McDonald, MD, PHD","SUB_INVESTIGATOR",{"type":62,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[64],{"name":65,"class":66},"Siemens Corporation, Corporate Technology","INDUSTRY","100598153","bbrilliant-revelation-comparision-study-100598153",false,"NCT07067788","B.Brilliant Revelation Comparision Study","A Clinical Comparison of Siemens Mammomat B.Brilliant , A Novel Wide-Angel Digitial Breast Tomosynthesis System With Siemens Mammomat Revelation , A Standard Wide-Angle Digital Breast Tomosynthesis System","Inclusion Criteria\n\n1. Participants will be ≥ 18 years of age.\n2. Participants will be females (sex assigned at birth).\n3. Participants will be presenting for clinical diagnostic mammography with suspicious calcifications or calcifications associated with other lesion types\n4. Participants must be informed of the investigational nature of this study and be willing to provide written informed consent and participate in this study in accordance with institutional and federal guidelines prior to study-specific procedures.\n\nExclusion Criteria\n\n1. Females who are breast-feeding will not be eligible for this study\n2. Pregnant women will not be included. All females of childbearing potential must attest that they are not pregnant.\n3. Inability to tolerate imaging procedures in the opinion of an investigator or treating physician.\n4. Any current medical condition, illness, or disorder, as assessed by medical record review and\u002For self-reported, that is considered by a physician investigator to be a condition that could compromise participant safety or successful participation in the study.",true,"FEMALE","18 Years",{"count":78,"type":79},100,"ESTIMATED","OBSERVATIONAL","This is an observational study to evaluate the MAMMOMAT B.brilliant system. All diagnostic decisions are made by the treating radiologist based upon standard of care clinical imaging acquired on FDA approved devices",[83],"Breast Cancer Screening",[85,86,87,88],"breast","mammogram","breast cancer","female","2026-04-23",{"date":91,"type":92},"2026-04-24","ACTUAL",{"date":94,"type":92},"2025-12-15",{"date":96,"type":79},"2027-01-30",{"name":5,"class":6},1]